THE ROLE OF CERTAIN BLOOD CYTOKINES AND FACTORS OF INNATE IMMUNITY FOR PREDICTION OF REACTIVE ARTHRITIS OUTCOME
- 作者: Chelpachenko O.1, Danilova E.1, Nikiforov I.1, Fedotova L.1
-
隶属关系:
- Institute of Cellular and Intracellular Symbiosis, Ural Branch of the Russian Academy of Sciences
- 期: 卷 20, 编号 3 (2017)
- 页面: 559-561
- 栏目: Articles
- URL: https://journals.rcsi.science/1028-7221/article/view/120043
- ID: 120043
如何引用文章
全文:
详细
The clinical and immunological examination of children with reactive arthritis (ReA) and discriminant analysis allowed to establish significant serum factors associated with the clinical variant of ReA (IL-17, IL-6, INF-γ, lysozyme, CRP), which indicates a possible Use them as markers for predicting the clinical course of ReA and the outcome of arthritis.
作者简介
O. Chelpachenko
Institute of Cellular and Intracellular Symbiosis, Ural Branch of the Russian Academy of Sciences
编辑信件的主要联系方式.
Email: noemail@neicon.ru
俄罗斯联邦
E. Danilova
Institute of Cellular and Intracellular Symbiosis, Ural Branch of the Russian Academy of Sciences
Email: noemail@neicon.ru
俄罗斯联邦
I. Nikiforov
Institute of Cellular and Intracellular Symbiosis, Ural Branch of the Russian Academy of Sciences
Email: noemail@neicon.ru
俄罗斯联邦
L. Fedotova
Institute of Cellular and Intracellular Symbiosis, Ural Branch of the Russian Academy of Sciences
Email: noemail@neicon.ru
俄罗斯联邦
参考
- Scher J. U. Microbiome in inflammatory arthritis and human rheumatic diseases / J. U. Scher, D. R. Littman, S. B. Abramson // Arthritis Rheumatol.- 2016.- Vol.68, N.1.- P. 35-45.
- Sieper J. Pathogenesis of reactive arthritis / J. Sieper // Curr Rheumatol Rep.- 2001.- N. 3.- P. 412-418.
- Rosenbaum J. T. The microbiome: A revolution in treatment for rheumatic diseases? / J. T. Rosenbaum, M. J. Asquith // Curr. Rheumatol. Rep.- 2016.- N. 18.- P. 62.
- Elevated levels of serum MRP8/14 in ankylosing spondylitis: Associated with peripheral arthritis and active disease / L. Gupta, S. Bhattacharya, V. Ag-garwal et al. // Clin. Rheumatol.- 2016.- Vol. 35, N.12.- P. 3075-3079.